Wegovy 1mg is a subcutaneous injectable prescription medication containing semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It is indicated as a pharmacological adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.

Dosage & Administration

• Dosage: Adhere strictly to the dosing schedule and administration instructions provided by your physician.
• Inject subcutaneously into the abdomen, thigh, or upper arm.
• Ensure solution clarity prior to use; do not inject if the liquid is cloudy, colored, or contains particulate matter.

Technical Specification

• Form: Aqueous solution for injection in a multi-dose pre-filled pen (FlexTouch).
• Primary Active: Semaglutide
• Delivery System: FlexTouch pen calibrated for 4 fixed doses of 1mg.

Ingredient Functionality

• Semaglutide: Mimics endogenous human GLP-1 (94% structural homology) to regulate appetite via the gut-brain axis. It enhances satiety, slows gastric emptying, and modulates hypothalamic hunger signals to reduce total caloric intake.
• Sodium Phosphate Dibasic Dihydrate: Acts as a buffering agent to stabilize the pH of the isotonic solution (pH ≈ 7.4).

Safety & Storage

• Refrigerate at 2°C to 8°C until first use; do not freeze.
• Post-activation storage: May be kept at room temperature (below 30°C) or refrigerated for up to 6 weeks.
• Light Protection: Always store the pen with the cap on in the original carton to prevent degradation.